A Replication Study for Association of ITPKC and CASP3 Two-Locus Analysis in IVIG Unresponsiveness and Coronary Artery Lesion in Kawasaki Disease

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Kuo, Ho Chang ^a   Hsu, Yu Wen ^b   Wu, Chung Min ^c   Chen, Shawn Hsiang Yin ^b   Hung, Kuo Sheng ^d   Chang, Wei Pin ^e   Yang, Kuender D ^f   Hsieh, Kai Sheng ^g   Chen, Wei Chiao ^h   Onouchi, Yoshihiro ⁱ   Chang, Wei Chiao ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e YUANPEI UNIVERSITY   (Taiwan)

^f SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^g KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

ⁱ RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CASPASE 3; IMMUNOGLOBULIN; INOSITOL TRISPHOSPHATE 3 KINASE;

ARTICLE; CASP3 GENE; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; INFANT; ITPKC GENE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWANESE;

EID: 84880826298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069685     Document Type: Article

References (42)

1. Kuo HC, Chang WC, (2011) Genetic polymorphisms in Kawasaki disease. Acta Pharmacol Sin 32: 1193-1198.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H, (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54: 271-276.
3. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD, (2005) Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 24: 998-1004.
4. Burns JC, Glode MP, (2004) Kawasaki syndrome. Lancet 364: 533-544.
5. Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, et al. (2010) Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 99: 1578-1583.
6. Hinks A, Ke X, Barton A, Eyre S, Bowes J, et al. (2009) Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum 60: 251-257.
7. Dendrou CA, Plagnol V, Fung E, Yang JH, Downes K, et al. (2009) Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet 41: 1011-1015.
8. Qu HQ, Verlaan DJ, Ge B, Lu Y, Lam KC, et al. (2009) A cis-acting regulatory variant in the IL2RA locus. J Immunol 183: 5158-5162.
9. Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, et al. (2009) Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 123: e401-405.
10. Townley RG, Barlan IB, Patino C, Vichyanond P, Minervini MC, et al. (2004) The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. Ann Allergy Asthma Immunol 92: 350-355.
11. Liang CD, Kuo HC, Yang KD, Wang CL, Ko SF, (2009) Coronary artery fistula associated with Kawasaki disease. Am Heart J 157: 584-588.
12. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110: 2747-2771.
13. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, et al. (2009) A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 5: e1000319.
14. Kim JJ, Hong YM, Sohn S, Jang GY, Ha KS, et al. (2011) A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 129: 487-495.
15. Tsai FJ, Lee YC, Chang JS, Huang LM, Huang FY, et al. (2011) Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study. PLoS One 6: e16853.
16. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, et al. (2011) Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 43: 1241-1246.
17. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, et al. (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44: 517-521.
18. Kuo HC, Yu HR, Juo SH, Yang KD, Wang YS, et al. (2011) CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. J Hum Genet 56: 161-165.
19. Kuo HC, Yang KD, Juo SH, Liang CD, Chen WC, et al. (2011) ITPKC Single Nucleotide Polymorphism Associated with the Kawasaki Disease in a Taiwanese Population. PLoS One 6: e17370.
20. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, et al. (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40: 35-42.
21. Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, et al. (2010) Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 19: 2898-2906.
22. Kuo HC, Lin YJ, Juo SH, Hsu YW, Chen WC, et al. (2011) Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese children. J Clin Immunol 31: 650-655.
23. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, et al. (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324: 1633-1639.
24. Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, et al. (2003) Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 111: E140-147.
25. Wang CL, Wu YT, Lee CJ, Liu HC, Huang LT, et al. (2002) Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 141: 560-565.
26. Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, et al. (2007) The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol 18: 354-359.
27. Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, et al. (2007) Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. J Microbiol Immunol Infect 40: 395-400.
28. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, et al. (2011) Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 4: 16-25.
29. Kuo HC, Onouchi Y, Hsu YW, Chen WC, Huang JD, et al. (2011) Polymorphisms of transforming growth factor-beta signaling pathway and Kawasaki disease in the Taiwanese population. J Hum Genet 56: 840-845.
30. Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, et al. (2011) ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease. Pharmacogenomics J.
31. Kuo HC, Liang CD, Yu HR, Wang CL, Lin IC, et al. (2010) CTLA-4, Position 49 A/G Polymorphism Associated with Coronary Artery Lesions in Kawasaki Disease. J Clin Immunol.
32. Kuo HC, Wang CL, Liang CD, Yu HR, Huang CF, et al. (2009) Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol 20: 266-272.
33. Yu HR, Kuo HC, Sheen JM, Wang L, Lin IC, et al. (2009) A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Pediatr Allergy Immunol 20: 699-707.
34. Shulman ST, De Inocencio J, Hirsch R, (1995) Kawasaki disease. Pediatr Clin North Am 42: 1205-1222.
35. Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, et al. (2013) ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease. Pharmacogenomics J 13: 52-59.
36. Kawasaki T, (1967) [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 16: 178-222.
37. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP, (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17: 1144-1148.
38. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, et al. (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153: 117-121.
39. Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, et al. (2007) Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 356: 663-675.
40. Tse SM, Silverman ED, McCrindle BW, Yeung RS, (2002) Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 140: 450-455.
41. Lin MT, Wang JK, Yeh JI, Sun LC, Chen PL, et al. (2011) Clinical Implication of the C Allele of the ITPKC Gene SNP rs28493229 in Kawasaki Disease: Association With Disease Susceptibility and BCG Scar Reactivation. Pediatr Infect Dis J 30: 148-152.
42. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, et al. (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12: 806-819.